ECM
TBIO

ExodusPoint Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

ExodusPoint Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,632
Closed -$601K – 2805
2020
Q4 		$601K Sell
32,632
-4,308
-12% -$77.1K 0.01% 1139
2020
Q3 		$503K Buy
36,940
+23,365
+172% +$360K 0.01% 1013
2020
Q2 		$243K Buy
+13,575
New +$205K 0.01% 1429

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

ExodusPoint Capital Management's TBIO Position: Q1 2021 in Review

ExodusPoint Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 32,632 shares — an estimated $601K sold.

ExodusPoint Capital Management first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $601K in Q4 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • ExodusPoint Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 32,632 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $601K.
  • ExodusPoint Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • ExodusPoint Capital Management's Translate Bio, Inc. Common Stock position peaked at $601K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.